© 2020 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
Life Transitions
Study of LARC use in teen mothers prompts state policy change
July 20, 2020
Read about the impact when long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge.
Menopause symptoms through the seasons
July 10, 2020
A peak in hot fl ash reports was observed in July, while January had a trough in hot fl ash reports.
Early menopause and cardiovascular disease
July 09, 2020
The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”
Can a healthier diet reduce menopause symptoms?
June 22, 2020
New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).
PD-L1 CNA as a biomarker in metastatic breast cancer
June 10, 2020
Australian researchers believe that PD-L1 may have potential as an indicator of potential response to chemotherapy in women with metastatic breast cancer. That was based on results of a randomized trial, presented at the European Society for Medical Oncology in Lugano, Switzerland.
Vasomotor symptoms and faster epigenetic aging
May 21, 2020
Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.
Lessons learned from postmenopausal hormone therapy
May 12, 2020
The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.
Community intervention boosts LARC use among adolescents
May 06, 2020
Long-acting reversible contraception (LARC) use among sexually active female adolescents in Rochester, New York, rose from about 4% before a local community intervention to roughly 24% after the initiative.